Andrey Alexandrovich Butylin

Title: The Innovative Contributions of Andrey Alexandrovich Butylin

Introduction

Andrey Alexandrovich Butylin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. With one patent to his name, Butylin's work focuses on addressing critical health issues related to thrombotic conditions.

Latest Patents

Andrey Butylin's sole patent involves anticoagulant compounds and pharmaceutical compositions designed to treat thrombotic conditions. His invention is titled "Anticoagulant Compounds, Pharmaceutical Compositions on Their Basis to Treat Thrombotic Conditions, and Plasma-Substituting Solution to Correct Hypercoagulation Defects of Hemodilution." This patent introduces new chemical compounds that can serve as anticoagulants, effectively helping in the treatment of various thromboembolic complications, such as myocardial infarction, stroke, and deep vein thrombosis. Additionally, the compositions aim to assist in preventing hypercoagulation arising from injuries, surgeries, sepsis, and obstetric pathologies, thereby playing a vital role in disaster medicine and resuscitation.

Career Highlights

Butylin is associated with the company Bionika, where he applies his expertise in pharmaceuticals and innovations. His work at Bionika highlights his commitment to advancing medical solutions that can save lives and enhance patient care. His career reflects a deep dedication to research and the development of effective medical interventions.

Collaborations

Throughout his career, Andrey has worked alongside esteemed colleagues, including Elena Ivanovna Sinauridze and Fazoil Inoyatovich Ataullakhanov. Their collaborative efforts have contributed to the successful development and application of medical treatments aimed at improving health outcomes for patients suffering from serious medical conditions.

Conclusion

Andrey Alexandrovich Butylin stands out as a committed innovator in the pharmaceutical industry. His patent on anticoagulant compounds highlights his dedication to finding solutions for complex medical challenges. Through collaborations and his role at Bionika, Butylin continues to make strides in advancing health science, significantly impacting patient care and treatment methodologies.